Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products
The proposed product standard would limit the addictiveness of the most toxic and widely used tobacco products, which would have significant public health benefits for all age groups.
The main quantified benefits come from averted mortality and morbidity as a result of reduced prevalence for people who currently use combusted tobacco products, and reduced mortality from reduced exposure to secondhand smoke among people. Unquantified benefits include medical cost savings, productivity loss savings, reduced exposure to thirdhand smoke, and environmental impacts. We expect this proposed rule, if finalized, to impose costs on industry to follow the product standard, on the broader economy to repurpose land, labor, and capital, on consumers impacted by the product standard, and on FDA to enforce this product standard. In addition to benefits and costs, this rule would cause transfers from the Federal Government and State governments in the form of tax revenue, from firms in the form of reduced revenue, and transfers between or within firms to cover shifts in user fee obligations.
Regulatory Impact Analysis
Nicotine Product Standard Preliminary Regulatory Impact Analysis (PDF- 4.04MB)
Federal Register: 90 FR 5032
Publication Date: 01/16/2025
Docket: FDA-2024-N-5471